QELBREE
Active substance: viloxazine
CAPSULE, EXTENDED RELEASE · VILOXAZINE HYDROCHLORIDE 150 mg/1
United StatesActive
Marketing holder: Supernus Pharmaceuticals, Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- VILOXAZINE HYDROCHLORIDE · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-92d4-7134-864f-bce3f6d2ba12,01a1208f-92d4-7c24-864f-bce3f7b43909,01a12098-008d-7f21-8ca2-8b64721d50df;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 17772-132
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 17772-132 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 17772-132 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 17772-132 · Verified 2026-10-09 · open in source